Latest Rocketdna (ASX:RKT) News

Pentanet led the technology board with a 53.33% weekly rise, while Ava Risk Group and Acusensus also posted strong gains. Software subscriptions, AI tools and cloud services drove many company updates, but some early share-price gains faded.

RocketDNA Ltd has secured a $1 million contract extension from BHP Mitsubishi Alliance to continue its autonomous drone operations in the Bowen Basin until October 2026, reinforcing its position in mining tech.

Nanoveu led the week after live drone trials, while Gratifii slumped on deal changes and X2M dropped after a discounted capital raising. Across the tech board, buyers backed real revenue, cash receipts and contract wins, but punished dilution, legal noise and weak post-gap trading.

RocketDNA reported a 52% year-on-year revenue increase and expanded its autonomous drone operations with four new enterprise customers in Q2 FY26. The company also advanced software integration with Deswik to embed drone data into mine-planning workflows.

A tiny gold explorer, a battery materials stock and a biotech name led a week packed with dealmaking, drilling news and fresh funding. Resources did most of the heavy lifting, while several big gaps either held firm or gave back part of their early jump.

Big swings hit ASX tech as tiny GCM surged, Objective slumped on a Defence contract loss, and DXN fell despite landing new work. Away from the biggest price moves, the week was packed with raisings, acquisitions and fresh AI, quantum and enterprise contract news.

RocketDNA has fully deployed its Skylink® Operating System to all enterprise customers, driving over 1,000 active users and securing a 12-month pipeline of 25,000 pre-scheduled drone missions.

Space batteries, telecom AI and a healthcare software leadership change drove the week’s biggest moves in small-cap tech. Capital raisings and debt deals also shaped trading, with several early jumps fading as investors weighed dilution and execution risk.

RocketDNA Ltd is acquiring the remaining 40% of its Western Australian subsidiary in a $1 million share-based transaction, simplifying its group structure without operational changes.

Robotics, AI chips and defence software drove the week’s biggest technology moves, but not every early jump held. Investors chased clear revenue growth and contract wins, while cash pressure and equity raisings kept a lid on parts of the sector.

RocketDNA Ltd delivered a break-even operating cash flow quarter with $2.47 million revenue, driven by soaring autonomous drone usage and the debut of its Skylink® operating system.

Tech microcaps swung hard as funding news, contract wins and disclosure issues collided. The biggest falls came where investors saw either forced selling or more cash needs ahead.